Examples of random paths from the graph

--------------------------------------------Path number 1:
to provide a splint for immobilizing the elbow or wrist articulations of a patient during administration of an intravenous solution -------> 
to provide a therapeutic neck tractioning device -------> 
to provide a method of treating a patient with a medical device -------> 
to provide a method for administering a medicament which comprises adhering to the mucosa of the oral or nasal cavity a pharmaceutical preparation comprising PA1 (a) a water-swellable and mucosa-adhesive polymeric matrix comprising about 50 to about 95% by weight of a cellulose ether and about 50 to about 5% by weight of a homo- or copolymer of acrylic acid or a pharmaceutically acceptable salt thereof, and PA1 (b) dispersed therein, a pharmaceutically effective amount of the medicament, said preparation releasing continuously the medicament at a controlled rate; and causing the released medicament to be absorbed through the mucosa or enterally -------> 
to provide a method for delivering a therapeutic agent into the intestinal tract -------> 
to provide a handle for a medical device -------> 
to provide a surgical attachment -------> 
to provide a method of administering anesthesia -------> 
to provide a method for the treatment of a patient with a condition that is responsive to the administration of a drug -------> 
to provide a device for dispensing a dose of a medicament -------> 
to provide a device for administering a medication -------> 
to provide a medical solution packaging assembly
----------------------------------------------------Path number 2:
to treat inflammatory and pyretic conditions in mammals, including humans -------> 
to provide a medical device -------> 
to provide a method for administering a medicament which comprises adhering to the mucosa of the oral or nasal cavity a pharmaceutical preparation comprising PA1 (a) a water-swellable and mucosa-adhesive polymeric matrix comprising about 50 to about 95% by weight of a cellulose ether and about 50 to about 5% by weight of a homo- or copolymer of acrylic acid or a pharmaceutically acceptable salt thereof, and PA1 (b) dispersed therein, a pharmaceutically effective amount of the medicament, said preparation releasing continuously the medicament at a controlled rate; and causing the released medicament to be absorbed through the mucosa or enterally -------> 
to provide a method for delivering a therapeutic agent into the intestinal tract -------> 
to provide a handle for a medical device -------> 
to provide a surgical attachment -------> 
to provide a method of administering anesthesia -------> 
to provide a device for displacing a lumen within a patient in-vivo during a surgical procedure -------> 
to provide a method for determining the location of a patient's eye
----------------------------------------------------Path number 3:
to treat organophosphate exposure -------> 
to provide a medical device -------> 
to provide a method for administering a medicament which comprises adhering to the mucosa of the oral or nasal cavity a pharmaceutical preparation comprising PA1 (a) a water-swellable and mucosa-adhesive polymeric matrix comprising about 50 to about 95% by weight of a cellulose ether and about 50 to about 5% by weight of a homo- or copolymer of acrylic acid or a pharmaceutically acceptable salt thereof, and PA1 (b) dispersed therein, a pharmaceutically effective amount of the medicament, said preparation releasing continuously the medicament at a controlled rate; and causing the released medicament to be absorbed through the mucosa or enterally -------> 
to provide a device for orthodontic treatment -------> 
to provide a device for the treatment of skin diseases -------> 
to monitor a health characteristic of a user -------> 
to provide a method for monitoring a patient's condition -------> 
to provide a method for treating a subject in need of AAT therapy or treatment -------> 
to provide a handle for a medical device -------> 
to provide a surgical attachment -------> 
to provide a method of administering anesthesia -------> 
to provide a device for displacing a lumen within a patient in-vivo during a surgical procedure -------> 
to provide a method for determining the location of a patient's eye
----------------------------------------------------Path number 4:
to provide a composition for the determination of tri-iodo thyronine in human blood serum -------> 
to provide a device for the treatment of a patient -------> 
to provide a method for administering a medicament which comprises adhering to the mucosa of the oral or nasal cavity a pharmaceutical preparation comprising PA1 (a) a water-swellable and mucosa-adhesive polymeric matrix comprising about 50 to about 95% by weight of a cellulose ether and about 50 to about 5% by weight of a homo- or copolymer of acrylic acid or a pharmaceutically acceptable salt thereof, and PA1 (b) dispersed therein, a pharmaceutically effective amount of the medicament, said preparation releasing continuously the medicament at a controlled rate; and causing the released medicament to be absorbed through the mucosa or enterally -------> 
to provide a method for delivering a therapeutic agent into the intestinal tract -------> 
to provide a handle for a medical device -------> 
to provide a surgical attachment -------> 
to provide a method of administering anesthesia -------> 
to provide a device for displacing a lumen within a patient in-vivo during a surgical procedure -------> 
to provide a method for determining the location of a patient's eye
----------------------------------------------------Path number 5:
to provide a method for preparing a conjugate of insulin and ragweed antigen E -------> 
to provide a method of treating a patient with a medical device -------> 
to provide a method for administering a medicament which comprises adhering to the mucosa of the oral or nasal cavity a pharmaceutical preparation comprising PA1 (a) a water-swellable and mucosa-adhesive polymeric matrix comprising about 50 to about 95% by weight of a cellulose ether and about 50 to about 5% by weight of a homo- or copolymer of acrylic acid or a pharmaceutically acceptable salt thereof, and PA1 (b) dispersed therein, a pharmaceutically effective amount of the medicament, said preparation releasing continuously the medicament at a controlled rate; and causing the released medicament to be absorbed through the mucosa or enterally -------> 
to provide a method for delivering a therapeutic agent into the intestinal tract -------> 
to provide a handle for a medical device -------> 
to provide a surgical attachment -------> 
to provide a method of administering anesthesia -------> 
to provide a device for displacing a lumen within a patient in-vivo during a surgical procedure -------> 
to provide a method for determining the location of a patient's eye
----------------------------------------------------Path number 6:
to provide a prosthetic heart valve -------> 
to provide a medical device -------> 
to provide a method for administering a medicament which comprises adhering to the mucosa of the oral or nasal cavity a pharmaceutical preparation comprising PA1 (a) a water-swellable and mucosa-adhesive polymeric matrix comprising about 50 to about 95% by weight of a cellulose ether and about 50 to about 5% by weight of a homo- or copolymer of acrylic acid or a pharmaceutically acceptable salt thereof, and PA1 (b) dispersed therein, a pharmaceutically effective amount of the medicament, said preparation releasing continuously the medicament at a controlled rate; and causing the released medicament to be absorbed through the mucosa or enterally -------> 
to provide a device for orthodontic treatment -------> 
to provide a method of treating skin conditions -------> 
to monitor a health characteristic of a user -------> 
to provide a method for monitoring a patient's condition -------> 
to provide a method of treating a disease or condition -------> 
to provide a handle for a medical device -------> 
to provide a surgical attachment -------> 
to provide a method of administering anesthesia -------> 
to provide a method for the treatment of a patient with a condition that is responsive to the administration of a drug -------> 
to provide a device for dispensing a dose of a medicament -------> 
to monitor drug dosage -------> 
to detect a test substance
----------------------------------------------------Path number 7:
to provide a method for treating a patient with a condition characterized by an increase in blood acetaldehyde levels -------> 
to provide a device for the treatment of a patient -------> 
to provide a method for administering a medicament which comprises adhering to the mucosa of the oral or nasal cavity a pharmaceutical preparation comprising PA1 (a) a water-swellable and mucosa-adhesive polymeric matrix comprising about 50 to about 95% by weight of a cellulose ether and about 50 to about 5% by weight of a homo- or copolymer of acrylic acid or a pharmaceutically acceptable salt thereof, and PA1 (b) dispersed therein, a pharmaceutically effective amount of the medicament, said preparation releasing continuously the medicament at a controlled rate; and causing the released medicament to be absorbed through the mucosa or enterally -------> 
to provide a device for orthodontic treatment -------> 
to provide a device for the treatment of skin diseases -------> 
to monitor a health characteristic of a user -------> 
to provide a method for monitoring a patient's condition -------> 
to provide a method of treating a disease or disorder -------> 
to provide a handle for a medical device -------> 
to provide a surgical attachment -------> 
to provide a method of administering anesthesia -------> 
to provide a method for treating pain by administering a pharmaceutical composition to a subject in need thereof -------> 
to provide a device for dispensing a dose of a medicament -------> 
to monitor drug dosage -------> 
to provide a dosage device
----------------------------------------------------Path number 8:
to describe a new class of antidepressants -------> 
to provide a new anti-hypertensive agent -------> 
to describe a new class of antianxiety agents -------> 
to provide a new class of analgesics -------> 
to provide a new class of anthelmintic agents -------> 
to produce a new antibiotic -------> 
to provide a method of treating a patient with a medical device -------> 
to provide a method for administering a medicament which comprises adhering to the mucosa of the oral or nasal cavity a pharmaceutical preparation comprising PA1 (a) a water-swellable and mucosa-adhesive polymeric matrix comprising about 50 to about 95% by weight of a cellulose ether and about 50 to about 5% by weight of a homo- or copolymer of acrylic acid or a pharmaceutically acceptable salt thereof, and PA1 (b) dispersed therein, a pharmaceutically effective amount of the medicament, said preparation releasing continuously the medicament at a controlled rate; and causing the released medicament to be absorbed through the mucosa or enterally -------> 
to provide a device for orthodontic treatment -------> 
to provide a method of treating skin conditions -------> 
to monitor a health characteristic of a user -------> 
to provide a method for monitoring a patient's condition -------> 
to provide a method of treating a disease or disorder -------> 
to provide a handle for a medical device -------> 
to provide a surgical attachment -------> 
to provide a method of administering anesthesia -------> 
to provide a method for the treatment of a patient with a condition that is responsive to the administration of a drug -------> 
to provide a method for delivering a medical agent to a treatment site -------> 
to provide a device for administering a medication -------> 
to provide a medical solution packaging assembly
----------------------------------------------------Path number 9:
to provide a method for improving the accuracy of medical imaging -------> 
to provide a method of treating a patient with a medical device -------> 
to provide a method for administering a medicament which comprises adhering to the mucosa of the oral or nasal cavity a pharmaceutical preparation comprising PA1 (a) a water-swellable and mucosa-adhesive polymeric matrix comprising about 50 to about 95% by weight of a cellulose ether and about 50 to about 5% by weight of a homo- or copolymer of acrylic acid or a pharmaceutically acceptable salt thereof, and PA1 (b) dispersed therein, a pharmaceutically effective amount of the medicament, said preparation releasing continuously the medicament at a controlled rate; and causing the released medicament to be absorbed through the mucosa or enterally -------> 
to provide a method for delivering a therapeutic agent into the intestinal tract -------> 
to provide a handle for a medical device -------> 
to provide a surgical attachment -------> 
to provide a method of administering anesthesia -------> 
to provide a device for displacing a lumen within a patient in-vivo during a surgical procedure -------> 
to provide a method for determining the location of a patient's eye
----------------------------------------------------Path number 10:
to provide a method for measuring the refractive error of a patient -------> 
to provide a medical device -------> 
to provide a method for administering a medicament which comprises adhering to the mucosa of the oral or nasal cavity a pharmaceutical preparation comprising PA1 (a) a water-swellable and mucosa-adhesive polymeric matrix comprising about 50 to about 95% by weight of a cellulose ether and about 50 to about 5% by weight of a homo- or copolymer of acrylic acid or a pharmaceutically acceptable salt thereof, and PA1 (b) dispersed therein, a pharmaceutically effective amount of the medicament, said preparation releasing continuously the medicament at a controlled rate; and causing the released medicament to be absorbed through the mucosa or enterally -------> 
to provide a device for orthodontic treatment -------> 
to provide a method of treating skin conditions -------> 
to monitor a health characteristic of a user -------> 
to provide a method for monitoring a patient's condition -------> 
to provide a method for treating a subject in need of AAT therapy or treatment -------> 
to provide a handle for a medical device -------> 
to provide a surgical attachment -------> 
to provide a method of administering anesthesia -------> 
to provide a device for displacing a lumen within a patient in-vivo during a surgical procedure -------> 
to provide a stabilizing fitting for an intravenous catheter -------> 
to provide a needle safety device -------> 
to provide a device for delivering an active substance to the eye -------> 
to provide a prosthetic device
----------------------------------------------------Path number 11:
to provide a method for separating granulocytes from blood -------> 
to provide a medical device -------> 
to provide a method for administering a medicament which comprises adhering to the mucosa of the oral or nasal cavity a pharmaceutical preparation comprising PA1 (a) a water-swellable and mucosa-adhesive polymeric matrix comprising about 50 to about 95% by weight of a cellulose ether and about 50 to about 5% by weight of a homo- or copolymer of acrylic acid or a pharmaceutically acceptable salt thereof, and PA1 (b) dispersed therein, a pharmaceutically effective amount of the medicament, said preparation releasing continuously the medicament at a controlled rate; and causing the released medicament to be absorbed through the mucosa or enterally -------> 
to provide a method for delivering a therapeutic agent into the intestinal tract -------> 
to provide a handle for a medical device -------> 
to provide a surgical attachment -------> 
to provide a method of administering anesthesia -------> 
to provide a method for treating pain by administering a pharmaceutical composition to a subject in need thereof -------> 
to provide a device for dispensing a dose of a medicament -------> 
to monitor drug dosage -------> 
to detect a test substance
----------------------------------------------------Path number 12:
to provide a method for the treatment of macular oedema -------> 
to provide a device for the treatment of a patient -------> 
to provide a method for administering a medicament which comprises adhering to the mucosa of the oral or nasal cavity a pharmaceutical preparation comprising PA1 (a) a water-swellable and mucosa-adhesive polymeric matrix comprising about 50 to about 95% by weight of a cellulose ether and about 50 to about 5% by weight of a homo- or copolymer of acrylic acid or a pharmaceutically acceptable salt thereof, and PA1 (b) dispersed therein, a pharmaceutically effective amount of the medicament, said preparation releasing continuously the medicament at a controlled rate; and causing the released medicament to be absorbed through the mucosa or enterally -------> 
to provide a device for orthodontic treatment -------> 
to provide a device for the treatment of skin diseases -------> 
to monitor a health characteristic of a user -------> 
to provide a method for monitoring a patient's condition -------> 
to provide a method of treating a disease or condition -------> 
to provide a handle for a medical device -------> 
to provide a surgical attachment -------> 
to provide a method of administering anesthesia -------> 
to provide a device for displacing a lumen within a patient in-vivo during a surgical procedure -------> 
to provide a stabilizing fitting for an intravenous catheter -------> 
to provide a needle safety device -------> 
to provide a device for delivering an active substance to the eye -------> 
to provide a prosthetic device
----------------------------------------------------Path number 13:
to describe a new method of treating cystic fibrosis -------> 
to provide a device for the treatment of a patient -------> 
to provide a method for administering a medicament which comprises adhering to the mucosa of the oral or nasal cavity a pharmaceutical preparation comprising PA1 (a) a water-swellable and mucosa-adhesive polymeric matrix comprising about 50 to about 95% by weight of a cellulose ether and about 50 to about 5% by weight of a homo- or copolymer of acrylic acid or a pharmaceutically acceptable salt thereof, and PA1 (b) dispersed therein, a pharmaceutically effective amount of the medicament, said preparation releasing continuously the medicament at a controlled rate; and causing the released medicament to be absorbed through the mucosa or enterally -------> 
to provide a device for orthodontic treatment -------> 
to provide a method of treating skin conditions -------> 
to monitor a health characteristic of a user -------> 
to provide a method for scanning a patient -------> 
to provide a method of treating a disease or disorder -------> 
to provide a handle for a medical device -------> 
to provide a surgical attachment -------> 
to provide a method of administering anesthesia -------> 
to provide a device for displacing a lumen within a patient in-vivo during a surgical procedure -------> 
to provide a stabilizing fitting for an intravenous catheter -------> 
to provide a needle safety device -------> 
to provide a device for delivering an active substance to the eye -------> 
to provide a prosthetic device
----------------------------------------------------Path number 14:
to provide a bed that can be used by a patient who is unable to walk -------> 
to provide a device for the treatment of a patient -------> 
to provide a method for administering a medicament which comprises adhering to the mucosa of the oral or nasal cavity a pharmaceutical preparation comprising PA1 (a) a water-swellable and mucosa-adhesive polymeric matrix comprising about 50 to about 95% by weight of a cellulose ether and about 50 to about 5% by weight of a homo- or copolymer of acrylic acid or a pharmaceutically acceptable salt thereof, and PA1 (b) dispersed therein, a pharmaceutically effective amount of the medicament, said preparation releasing continuously the medicament at a controlled rate; and causing the released medicament to be absorbed through the mucosa or enterally -------> 
to provide a device for orthodontic treatment -------> 
to provide a method of treating skin conditions -------> 
to monitor a health characteristic of a user -------> 
to provide a method for monitoring a patient's condition -------> 
to provide a method for treating a subject in need of AAT therapy or treatment -------> 
to provide a handle for a medical device -------> 
to provide a surgical attachment -------> 
to provide a method of administering anesthesia -------> 
to provide a method for the treatment of a patient with a condition that is responsive to the administration of a drug -------> 
to provide a method for delivering a medical agent to a treatment site -------> 
to provide a device for administering a medication -------> 
to provide a medical solution packaging assembly
----------------------------------------------------Path number 15:
to provide a method of treating a patient with a balloon catheter -------> 
to provide a device for the treatment of a patient -------> 
to provide a method for administering a medicament which comprises adhering to the mucosa of the oral or nasal cavity a pharmaceutical preparation comprising PA1 (a) a water-swellable and mucosa-adhesive polymeric matrix comprising about 50 to about 95% by weight of a cellulose ether and about 50 to about 5% by weight of a homo- or copolymer of acrylic acid or a pharmaceutically acceptable salt thereof, and PA1 (b) dispersed therein, a pharmaceutically effective amount of the medicament, said preparation releasing continuously the medicament at a controlled rate; and causing the released medicament to be absorbed through the mucosa or enterally -------> 
to provide a device for orthodontic treatment -------> 
to provide a method of treating skin conditions -------> 
to monitor a health characteristic of a user -------> 
to provide a method for monitoring a patient's condition -------> 
to provide a method of treating a patient with a disease or condition -------> 
to provide a handle for a medical device -------> 
to provide a surgical attachment -------> 
to provide a method of administering anesthesia -------> 
to provide a method for treating pain by administering a pharmaceutical composition to a subject in need thereof -------> 
to provide a device for dispensing a dose of a medicament -------> 
to provide a method for the preparation of a pharmaceutical composition -------> 
to provide a method of manufacturing a medical device -------> 
to provide a medical solution packaging assembly
----------------------------------------------------Path number 16:
to provide a stationary exercise bike -------> 
to provide a composition with procoagulant cells and at least one factor Xa inhibitor, preferably rivaroxaban, as well as at least one thrombin inhibitor, preferably bivalirudin -------> 
to provide a method for prophylaxis or treatment of ErbB1 positive cancers -------> 
to provide a method of treating a patient with a condition characterized by a deficiency of a protein
----------------------------------------------------Path number 17:
to provide a method for treating phenylketonuria -------> 
to provide a method of treating a patient with a medical device -------> 
to provide a method for administering a medicament which comprises adhering to the mucosa of the oral or nasal cavity a pharmaceutical preparation comprising PA1 (a) a water-swellable and mucosa-adhesive polymeric matrix comprising about 50 to about 95% by weight of a cellulose ether and about 50 to about 5% by weight of a homo- or copolymer of acrylic acid or a pharmaceutically acceptable salt thereof, and PA1 (b) dispersed therein, a pharmaceutically effective amount of the medicament, said preparation releasing continuously the medicament at a controlled rate; and causing the released medicament to be absorbed through the mucosa or enterally -------> 
to provide a method for delivering a therapeutic agent into the intestinal tract -------> 
to provide a handle for a medical device -------> 
to provide a surgical attachment -------> 
to provide a method of administering anesthesia -------> 
to provide a method for the treatment of a patient with a condition that is responsive to the administration of a drug -------> 
to provide a device for dispensing a dose of a medicament -------> 
to monitor drug dosage -------> 
to detect a test substance
----------------------------------------------------Path number 18:
to provide a method of treating and/or preventing Dravet Syndrome in a patient such as a patient previously diagnosed with Dravet Syndrome, by administering an effective dose of fenfluramine or its pharmaceutically acceptable salt to that patient -------> 
to provide a device for the treatment of a patient -------> 
to provide a method for administering a medicament which comprises adhering to the mucosa of the oral or nasal cavity a pharmaceutical preparation comprising PA1 (a) a water-swellable and mucosa-adhesive polymeric matrix comprising about 50 to about 95% by weight of a cellulose ether and about 50 to about 5% by weight of a homo- or copolymer of acrylic acid or a pharmaceutically acceptable salt thereof, and PA1 (b) dispersed therein, a pharmaceutically effective amount of the medicament, said preparation releasing continuously the medicament at a controlled rate; and causing the released medicament to be absorbed through the mucosa or enterally -------> 
to provide a device for orthodontic treatment -------> 
to provide a method of treating skin conditions -------> 
to monitor a health characteristic of a user -------> 
to provide a method for monitoring a patient's condition -------> 
to provide a method of treating a patient with a disease or condition -------> 
to provide a handle for a medical device -------> 
to provide a surgical attachment -------> 
to provide a method of administering anesthesia -------> 
to provide a method for the treatment of a patient with a condition that is responsive to the administration of a drug -------> 
to provide a method for delivering a medical agent to a treatment site -------> 
to provide a device for administering a medication -------> 
to provide a medical solution packaging assembly
----------------------------------------------------Path number 19:
to provide a method for estimating a glucose level of a person having diabetes and selecting automatically open-loop and closed-loop control for a connected therapy delivery device -------> 
to provide a system for activating a cued health assessment -------> 
to provide a medical device -------> 
to provide a method for administering a medicament which comprises adhering to the mucosa of the oral or nasal cavity a pharmaceutical preparation comprising PA1 (a) a water-swellable and mucosa-adhesive polymeric matrix comprising about 50 to about 95% by weight of a cellulose ether and about 50 to about 5% by weight of a homo- or copolymer of acrylic acid or a pharmaceutically acceptable salt thereof, and PA1 (b) dispersed therein, a pharmaceutically effective amount of the medicament, said preparation releasing continuously the medicament at a controlled rate; and causing the released medicament to be absorbed through the mucosa or enterally -------> 
to provide a method for delivering a therapeutic agent into the intestinal tract -------> 
to provide a handle for a medical device -------> 
to provide a surgical attachment -------> 
to provide a method of administering anesthesia -------> 
to provide a device for displacing a lumen within a patient in-vivo during a surgical procedure -------> 
to provide a stabilizing fitting for an intravenous catheter -------> 
to provide a needle safety device -------> 
to provide a device for delivering an active substance to the eye -------> 
to provide a prosthetic device
----------------------------------------------------Path number 20:
to provide a method for determining the location of a mobile patient monitoring device -------> 
to provide a device for the treatment of a patient -------> 
to provide a method for administering a medicament which comprises adhering to the mucosa of the oral or nasal cavity a pharmaceutical preparation comprising PA1 (a) a water-swellable and mucosa-adhesive polymeric matrix comprising about 50 to about 95% by weight of a cellulose ether and about 50 to about 5% by weight of a homo- or copolymer of acrylic acid or a pharmaceutically acceptable salt thereof, and PA1 (b) dispersed therein, a pharmaceutically effective amount of the medicament, said preparation releasing continuously the medicament at a controlled rate; and causing the released medicament to be absorbed through the mucosa or enterally -------> 
to provide a method for delivering a therapeutic agent into the intestinal tract -------> 
to provide a handle for a medical device -------> 
to provide a surgical attachment -------> 
to provide a method of administering anesthesia -------> 
to provide a method for treating pain by administering a pharmaceutical composition to a subject in need thereof -------> 
to provide a device for dispensing a dose of a medicament -------> 
to provide a device for administering a medication -------> 
to provide a medical solution packaging assembly
----------------------------------------------------